National Center for Advancing Translational Sciences, National Institutes of Health
Dr. Wei Zheng received his Ph.D. in Pharmacology from the State University of New York at Buffalo. After his postdoctoral training, he had worked for twelve years in pharmaceutical companies including Berlex, Amgen, and Merck for drug discovery and development. Since 2005, Dr. Zheng has worked at National Institutes of Health for translational research and therapeutics development for rare and neglected diseases. He has actively working on the phenotypical screening using patient iPS cell derived neuronal cells, cardiomyocytes, and hepatocytes as well as employing new technologies for drug screening and for target identifications. He has identified several drugs for new indications from drug repurposing screens in which two of them have been advanced to clinical trials. Together with his colleagues, Dr. Zheng has authored over 170 scientific publications.
Tuesday, February 6
4:00 PM – 4:30 PM